1Hunter SW, Gaylord H, Brenuan PJ, et al. Structure and antigencity of the phosphory lated lipolysacharide antigens from the leprosy and tubercle bacilli[J].J Biol Chem, 1986,216:12345-12351.
5Walzl G,Ronacher K,Hanekom W.Immunological biomarkers of tuberculosis[J].Nat Rev Immunol,2011,11(5):343-354.
6World Health Organization.Global tuberculosis control:WHO report 2011[EB/OL].[2012-06-20].http://www.who.int/tb/publications/global_report/en/.
7McNerney R,Daley P.Towards a point-of-care test for active tuberculosis:obstacles and opportunities[J].Nat Rev Microbiol,2011,9(3):204-213.
8Wallis R S,Pai M,Menzies D.Biomarkers and diagnostics for tuberculosis:progress,needs,and translation into practice[J].Lancet,2010,375(9729):1920-1937.
9Lee W G,Kim Y G,Chung B G.Nano/Microfluidics for diagnosis of infectious diseases in developing countries[J].Adv Drug Deliv Rev,2010,62(4-5):449-457.
10Wang S,Xu F,Demirci U.Advances in developing HIV-1 viral load assays for resource-limited settings[J].Biotechnol Adv,2010,28(6):770-781.
